Byrne Joseph A. 5

Accession 0001437749-21-009956

CIK 0001653821other

View on SEC.gov Company Profile

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 8:33 AM ET

Size

43.5 KB

Accession

0001437749-21-009956

Insider Transaction Report

Form 5

Period: 2019-12-31

CEN BIOTECH INCCENBF

Byrne Joseph A.

DirectorChief Executive Officer*

Transactions

Other
Common Stock
2019-10-16+2,000→ 1,497,265 total
Other
Common Stock
2019-01-16+2,000→ 1,497,265 total
Other
Common Stock
2019-02-16+2,000→ 1,497,265 total
Other
Common Stock
2019-04-16+2,000→ 1,497,265 total
Other
Common Stock
2019-06-16+2,000→ 1,497,265 total
Other
Common Stock
2019-09-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-10-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-08-16+2,000→ 1,497,265 total
Other
Common Stock
2019-11-16+2,000→ 1,497,265 total
Other
Common Stock
2019-02-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-04-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-06-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-08-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-12-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-05-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-09-16+2,000→ 1,497,265 total
Other
Common Stock
2019-03-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-07-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-11-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-03-16+2,000→ 1,497,265 total
Other
Common Stock
2019-05-16+2,000→ 1,497,265 total
Other
Common Stock
2019-07-16+2,000→ 1,497,265 total
Other
Common Stock
2019-01-16+4,000→ 1,497,265 total(indirect: By Spouse)
Other
Common Stock
2019-12-16+2,000→ 1,497,265 total

Footnotes (3)

[F1]24,000 shares of common stock of the issuer held by Joseph Byrne (the "Reporting Person") were issued as consideration for extending the maturity date of a promissory note dated January 24, 2018 and were acquired in increments of 2,000 shares on the following dates: 01/16/2019; 02/16/2019; 03/16/2019; 04/16/2019; 05/16/2019; 06/16/2019; 07/16/2019; 08/16/2019; 09/16/2019; 10/16/2019; 11/16/2019; and 12/16/2019.
[F2]48,000 shares of common stock of the issuer were issued to the Reporting Person's spouse as consideration for extending the maturity date of a promissory note dated January 14, 2018 and were acquired in increments of 4,000 on the following dates: 01/16/2019; 02/16/2019; 03/16/2019; 04/16/2019; 05/16/2019; 06/16/2019; 07/16/2019; 08/16/2019; 09/16/2019; 10/16/2019; 11/16/2019; and 12/16/2019.
[F3]1,401,265 shares were beneficially owned by the Reporting Person of which 76,123 shares were issuable upon conversion of a convertible note held by the Reporting Person and 96,000 shares were held by the Reporting Person's spouse at 12/31/2019.

Documents

1 file

5
rdgdoc.xmlPrimary
FORM 5

Issuer

CEN BIOTECH INC

CIK 0001653821

→

Entity typeother

Related Parties

filerCIK 0001736911

Filing Metadata

Form type: 5
Filed: Apr 27, 8:00 PM ET
Accepted: Apr 28, 8:33 AM ET
Size: 43.5 KB

View on SEC.gov